WYZGA MICHAEL S

Director at Invivyd, Inc. · on record since May 25, 2023
Director at Altus Pharmaceuticals Inc. · on record since Jan 25, 2006
Executive VP and CFO at GENZYME CORP · on record since May 30, 2006
Director at OncoMed Pharmaceuticals Inc · on record since Oct 16, 2013
Director at IDENIX PHARMACEUTICALS INC · on record since Mar 2, 2012
Director at Radius Health, Inc. · on record since Jun 22, 2012
Chief Executive Officer at Radius Health, Inc. · on record since Jun 22, 2012
Director at ALLIED DEFENSE GROUP INC · on record since Aug 9, 2021
Director at Mereo BioPharma Group plc · on record since Feb 9, 2024
Director at Akebia Therapeutics, Inc. · on record since Mar 27, 2014
Director at Tvardi Therapeutics, Inc. · on record since Jun 11, 2026
Director at EXACT SCIENCES CORP · on record since Feb 10, 2015
Director at LogicBio Therapeutics, Inc. · on record since Oct 22, 2018
Director at X4 Pharmaceuticals, Inc · on record since Mar 14, 2019

Insider trading activity of WYZGA MICHAEL S

Transactions on record: 129; since Jun 1, 2004

Open-market buys: 2; $55.5K

Open-market sells: 10; $14.3M

Companies traded: 13; last filing Jun 11, 2026

Figures computed from official regulatory filings — .

Companies where WYZGA MICHAEL S has traded

Tvardi Therapeutics, Inc.3 tx · Jun 11, 2026
Mereo BioPharma Group plc6 tx · $99.9K · Feb 27, 2026
11 tx · $87K · Jan 5, 2026
1 tx · May 25, 2023
10 tx · Nov 17, 2022
2 tx · Jun 24, 2022
19 tx · $4M · Mar 2, 2021
6 tx · Jun 25, 2018
4 tx · $25.5K · Jun 15, 2018
10 tx · Aug 5, 2014
1 tx · $6M · Jun 22, 2012
51 tx · $49.3M · Apr 6, 2011
5 tx · Jul 2, 2009

Track record of WYZGA MICHAEL S

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of WYZGA MICHAEL S

Co-insiders of WYZGA MICHAEL S

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Tvardi Therapeutics, Inc.Listing unverified	Jun 11, 2026	AwardD (derivative)	6,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Mereo BioPharma Group plcListing unverified	Feb 27, 2026	AwardD (derivative)	66,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
X4 Pharmaceuticals, IncListing on record	Jan 5, 2026	AwardD (derivative)	110,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
X4 Pharmaceuticals, IncListing on record	Jun 10, 2025	Award	1,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Tvardi Therapeutics, Inc.Listing unverified	Apr 21, 2025	AwardD (derivative)	12,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Tvardi Therapeutics, Inc.Listing unverified	Apr 17, 2025	AwardD (derivative)	18,441	—	n/a (No price was disclosed in the filing)		SEC
Mereo BioPharma Group plcListing unverified	Feb 6, 2025	AwardD (derivative)	30,487	—	n/a (No price was disclosed in the filing)		SEC
Mereo BioPharma Group plcListing unverified	Feb 6, 2025	AwardD (derivative)	55,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Mereo BioPharma Group plcListing unverified	Jun 17, 2024	Award	25,050	3.99 USD	$99.9K	Unusual size	SEC
X4 Pharmaceuticals, IncListing on record	Jun 11, 2024	Award	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Mereo BioPharma Group plcListing unverified	Feb 9, 2024	AwardD (derivative)	30,783	—	n/a (No price was disclosed in the filing)		SEC
Mereo BioPharma Group plcListing unverified	Feb 9, 2024	AwardD (derivative)	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
X4 Pharmaceuticals, IncListing on record	Aug 22, 2023	Buy	25,000	1.20 USD	$30K	conv 70First in 12mo	SEC
X4 Pharmaceuticals, IncListing on record	Jun 14, 2023	Award	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Invivyd, Inc.Listing on record	May 25, 2023	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LogicBio Therapeutics, Inc.Listing unverified	Nov 17, 2022	OtherD (derivative)	-12,500	—	n/a (No price was disclosed in the filing)		SEC
LogicBio Therapeutics, Inc.Listing unverified	Nov 17, 2022	Other	-3,141	—	n/a (No price was disclosed in the filing)		SEC
X4 Pharmaceuticals, IncListing on record	Jun 27, 2022	Award	6,667	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ALLIED DEFENSE GROUP INCListing unverified	Jun 24, 2022	AwardD (derivative)	75,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LogicBio Therapeutics, Inc.Listing unverified	Jun 21, 2022	AwardD (derivative)	12,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ALLIED DEFENSE GROUP INCListing unverified	Aug 9, 2021	AwardD (derivative)	71,186	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LogicBio Therapeutics, Inc.Listing unverified	Jun 14, 2021	AwardD (derivative)	12,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
X4 Pharmaceuticals, IncListing on record	Jun 2, 2021	AwardD (derivative)	6,000	9.50 USD	$57K		SEC
EXACT SCIENCES CORPListing unverified	Mar 2, 2021	Sell	-19,021	130.11 USD	$2.5M		SEC
EXACT SCIENCES CORPListing unverified	Mar 2, 2021	ExerciseD (derivative)	-10,108	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Tvardi Therapeutics, Inc.Listing unverified	Jun 11, 2026	AwardD (derivative)	6,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Mereo BioPharma Group plcListing unverified	Feb 27, 2026	AwardD (derivative)	66,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
X4 Pharmaceuticals, IncListing on record	Jan 5, 2026	AwardD (derivative)	110,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
X4 Pharmaceuticals, IncListing on record	Jun 10, 2025	Award	1,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Tvardi Therapeutics, Inc.Listing unverified	Apr 21, 2025	AwardD (derivative)	12,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Tvardi Therapeutics, Inc.Listing unverified	Apr 17, 2025	AwardD (derivative)	18,441	—	n/a (No price was disclosed in the filing)		SEC
Mereo BioPharma Group plcListing unverified	Feb 6, 2025	AwardD (derivative)	30,487	—	n/a (No price was disclosed in the filing)		SEC
Mereo BioPharma Group plcListing unverified	Feb 6, 2025	AwardD (derivative)	55,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Mereo BioPharma Group plcListing unverified	Jun 17, 2024	Award	25,050	3.99 USD	$99.9K	Unusual size	SEC
X4 Pharmaceuticals, IncListing on record	Jun 11, 2024	Award	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Mereo BioPharma Group plcListing unverified	Feb 9, 2024	AwardD (derivative)	30,783	—	n/a (No price was disclosed in the filing)		SEC
Mereo BioPharma Group plcListing unverified	Feb 9, 2024	AwardD (derivative)	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
X4 Pharmaceuticals, IncListing on record	Aug 22, 2023	Buy	25,000	1.20 USD	$30K	conv 70First in 12mo	SEC
X4 Pharmaceuticals, IncListing on record	Jun 14, 2023	Award	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Invivyd, Inc.Listing on record	May 25, 2023	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LogicBio Therapeutics, Inc.Listing unverified	Nov 17, 2022	OtherD (derivative)	-12,500	—	n/a (No price was disclosed in the filing)		SEC
LogicBio Therapeutics, Inc.Listing unverified	Nov 17, 2022	Other	-3,141	—	n/a (No price was disclosed in the filing)		SEC
X4 Pharmaceuticals, IncListing on record	Jun 27, 2022	Award	6,667	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ALLIED DEFENSE GROUP INCListing unverified	Jun 24, 2022	AwardD (derivative)	75,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LogicBio Therapeutics, Inc.Listing unverified	Jun 21, 2022	AwardD (derivative)	12,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ALLIED DEFENSE GROUP INCListing unverified	Aug 9, 2021	AwardD (derivative)	71,186	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LogicBio Therapeutics, Inc.Listing unverified	Jun 14, 2021	AwardD (derivative)	12,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
X4 Pharmaceuticals, IncListing on record	Jun 2, 2021	AwardD (derivative)	6,000	9.50 USD	$57K		SEC
EXACT SCIENCES CORPListing unverified	Mar 2, 2021	Sell	-19,021	130.11 USD	$2.5M		SEC
EXACT SCIENCES CORPListing unverified	Mar 2, 2021	ExerciseD (derivative)	-10,108	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC